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 Following the diagnosis of absolute uterine factor infertility (AUFI), women 
may experience considerable psychological harm as a result of a loss of 
reproductive function and the realisation of permanent and irreversible 
infertility.  
 Adoption enables women with AUFI, and their partners, to experience social 
and legal parenthood, also often providing benefits for the adopted child. 
 Surrogacy offers the opportunity to have genetically related offspring. 
Outcomes are generally positive in both surrogates and the children born as a 
result.  
 Uterine transplantation is the only option to restore reproductive anatomy and 
functionality. While associated with considerable risk, it allows the experience 
of gestation and the achievement of biological, social and legal parenthood. 
 
Learning objectives 
 To gain an understanding of the routes to parenthood available for women 
with AUFI experiencing involuntary childlessness, such as adoption, 
surrogacy and, most recently, uterine transplantation 
 To consider a suggested management plan to facilitate counselling in women 
with AUFI who experience involuntary childlessness.  
 
Ethical issues 
 In the UK, whilst the number of children requiring adoption continues to 
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 Some cultures may hold ethical or religious beliefs that surrogacy is 
unacceptable, and its legal position in many jurisdictions is problematic. 
 Restrictive selection criteria and high costs may limit future availability of 
uterine transplantation  
 
Keywords 
 adoption / infertility / surrogacy / transplantation / uterus 
 
[Heading 1] Introduction 
Absolute uterine factor infertility (AUFI) is a form of infertility whereby conception 
and/or maintenance of pregnancy is impossible owing to uterine absence or 
dysfunction. AUFI may be congenital, such as in Mayer–Rokitansky–Küster–Hauser 
(MRKH) syndrome; acquired, following hysterectomy; or from the development of 
uterine pathology, such as severe Asherman’s syndrome. Regardless of aetiology, 
the diagnosis of AUFI is often sudden and unexpected, coming after investigation for 
primary amenorrhea, hypomenorrhea, or following urgent or unplanned 
hysterectomy. Others, such as those with severe Asherman’s syndrome, may be 
diagnosed after years of poor reproductive history, often following numerous 
unsuccessful hysteroscopic procedures. After diagnosis, women with AUFI 
experience the loss of reproductive function and the realisation of permanent and 
irreversible infertility, which is associated with considerable long-term emotional 
burden.1,2 Management of AUFI thus requires an integrated, multidisciplinary 
approach, involving gynaecologists, psychologists and clinical nurse specialists.3 
Additionally, particularly in conditions such as MRKH, when the diagnosis commonly 
occurs during adolescence, counselling and patient support groups can be 
particularly beneficial.4  
After a diagnosis of infertility, many women experience anxiety, depression, low self-
esteem, loss of gender identity, a decrease in their quality of life and an enduring 
sense of incompleteness and grief.5–8 Worse psychological outcomes arise in 
women experiencing infertility who fail to conceive after assisted reproductive 
technology (ART) treatment than in those who are successful.9 In low income and/or 
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socioeconomic implications arising from an infertility diagnosis, including a negative 
effect on social status and worsening marital discourse.10  
While childlessness, or remaining ‘child-free’, is a choice increasingly made by both 
genders,11 most women still expect to acquire motherhood by conceiving without 
medical assistance; carrying a pregnancy themselves and giving birth to their own 
children. However, women with AUFI who seek parenthood have – until recently – 
had no option but to change their reproductive plans and either accept involuntary 
childlessness or acquire parenthood through adoption or surrogacy. After more than 
70 uterine transplantation (UTx) procedures worldwide and at least 18 live births,12 
women with AUFI may soon be able to access an alternative route to parenthood 
that would allow them to conceive, gestate and give birth to their own children. 
However, despite the additional benefits it promises, UTx is associated with 
considerable risk and currently necessitates conception via in vitro fertilisation (IVF), 
a highly medicalised pregnancy and delivery by caesarean section. 
This review explores the options available for women with AUFI to acquire 
motherhood, discusses the advantages and disadvantages of each option and 
provides a suggested management algorithm for women with AUFI who experience 
involuntary childlessness, based on individual reproductive aspirations.  
 
[Heading 1] Adoption 
Adoption is the permanent transfer of parental rights and responsibility from a child’s 
birth parents to adoptive parents, creating a new family unit that will raise the child. 
For women with AUFI who seek parenthood, adoption benefits include social and 
legal parenthood and an opportunity to enhance the lives of children whose genetic 
parents are unable to care for them.13 In the UK, the number of children defined as 
being under the care of local authorities has increased every year since 2013. This is 
primarily associated with an increased number of care orders, resulting in 78 150 
children in care in 2018/19. In contrast to this rise, the number of children who are 
adopted from care continues to decrease, with just 3570 adoptions in the same 
period.14  
While adoption is usually a mutually beneficial arrangement for both parents and 
their adopted children, it is often associated with several challenges or attachment-
related difficulties that require consideration for prospective parents. Of all children 
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neglect.14 Adopted children are more likely to be diagnosed with emotional, 
behavioural and relational difficulties and15,16 to access mental health services in the 
future,13 and fare worse in terms of academic attainment17 compared with children 
under the guardianship of their birth parents. Adverse outcomes extend into 
adulthood.18 However, successful placements with adoptive families have resulted in 
better psychological development and wellbeing outcomes for previously looked-
after children, especially when adopted at a younger age.19–21  
Potential adopters may find adopting a daunting prospect. It can be a very lengthy 
process, typically including a formal evaluation process involving references, 
background checks and home visits, before a training period and a more detailed 
assessment, while the adoption agency seeks a good match between child and 
potential adopters. In the UK, this matching process can take up to 2 years22 and is 
by no means guaranteed. There is the additional insecurity that the child may not 
even subsequently be relinquished from their birth parents. Initial reports portrayed 
outcomes for adoptive parents to be inferior to biological ones, with suggestions of 
increased anxiety, anger, grief and inability to bond.23,24 However, more recent 
studies have suggested positive outcomes for parents following adoption, with three-
quarters of adoptive parents reporting a positive effect on their family.25,26  
The realities of adoption are undoubtedly associated with numerous challenges. This 
is exemplified by a recent unpublished survey from almost 2700 adopters, 
undertaken in collaboration with Adoption UK.27 More than one-quarter of parents 
responding to this survey described serious effects on the wider family, or that their 
wider family relationships were at risk or had already been disrupted. Around half of 
respondents found it challenging but stable and one-quarter purported it to be 
fulfilling and stable. Despite almost two-thirds reporting aggressive behaviour 
towards them from their child, most (88%) were glad that they adopted. Another 
study identified that 9–13% of adoptions broke down and 21–25% were finding it 
difficult,28 further highlighting the challenges faced by adoptive families. Unrealistic 
expectations, particularly with regards to subsequent academic achievement, have 
also been identified as factors affecting adjustment.29 From a psychological 
perspective, adoptive parents have reported similarly positive depression, self-
esteem and wellbeing scores when compared with biological parents.30 
Cross-border adoption entails the legal adoption of children born in other countries. 
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adoption offers the opportunity for vulnerable children, mostly from low income, 
undeveloped countries, to be raised in a wealthier country, with better healthcare, 
education and opportunities. However, whereas there is unquestionable opportunity 
for great benefit, considerable challenges remain in relation to safeguarding and 
exploitation, including the potential for the illicit movement of vulnerable children who 
have been illegally separated from their families. Further issues stimulating debate 
relate to the cultural identity of children following cross-border adoption.31 
 
[Heading 1] Surrogacy 
Surrogacy is the process whereby a woman (the surrogate) gestates and gives birth 
with a pre-arranged plan of giving the child to another person or couple; the 
‘intended’ parents. Surrogacy arrangements can be paid (‘commercial’) or unpaid 
(‘altruistic’). They are also commonly divided into ‘full’, or ‘straight’ or ‘traditional’ 
surrogacy arrangements, and ‘host’, or ‘gestational’ surrogacy. In full surrogacy, the 
surrogate provides her own eggs, so is genetically related to the child. In host 
surrogacy, she does not; the eggs may come either from the intended parents or an 
egg donor. The occurrence of AUFI provides a strong prima facie justification for 
utilising surrogacy.32 In such women, gestational surrogacy is considerably more 
prevalent than full surrogacy because, subject to satisfactory ovarian reserve, it 
allows them to be biologically related to their children. Thousands of children have 
now been born using surrogacy arrangements.33 However, some cultures or families 
may still hold ethical or religious beliefs that surrogacy is unacceptable. Furthermore, 
surrogacy’s legal position in many jurisdictions is problematic. 
Surrogacy regulation varies internationally and between US states, as represented in 
Figure 1. Paid, commercial surrogacy is permitted and legally enforceable in certain 
countries including Russia, Ukraine and Georgia. In other countries, only unpaid, 
altruistic surrogacy is permitted, with paid arrangements and their brokerage being 
forbidden. Countries where this applies include the UK, Australia, Canada, Brazil, 
India and South Africa. In many areas of the world, including most of Western 
Europe, China, Japan, Pakistan, Turkey, Saudi Arabia and some areas of North 
America, restrictive legislation explicitly or effectively forbids all forms of surrogacy. 
Thus, it is excluded as a possibility for more than one-third of the world’s population. 
A recent survey orchestrated by the International Federation of Fertility Societies 
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permitted by statute or guideline in just 38% of the countries represented, and 
prohibited in 56%.34  
Although the UK was one of the first countries to introduce a regulatory framework 
for ART, subsequent legislative reforms have received criticism.35 The Surrogacy 
Arrangements Act 1985 was heavily influenced by recommendations from the 
Committee of Inquiry into Human Fertilisation and Embryology 1984, referred to as 
the Warnock Report.36 The Warnock Report highlighted concerns about the potential 
use of financial incentives in surrogacy commercialisation to exploit vulnerable 
women. Central to the Surrogacy Arrangements Act 1985 was the prohibition of 
commercial surrogacy. However, no safeguards were put in place to protect intended 
parents or surrogates and the welfare of subsequent children was not addressed. 
Such safeguards were not put in place until the enactment of the Human Fertilisation 
and Embryology Act 1990, which provided a legal framework for transfer of parental 
rights from surrogates to the intended parents and incorporated a welfare principle. 
Surrogacy is permitted in the UK, but surrogacy agreements are not legally 
enforceable. This means that the surrogate will be the child’s legal mother at birth, 
regardless of the origin of the gametes that created the embryo. If the surrogate is 
married, then her husband, who is biologically unrelated to the child, would 
automatically be considered the legal father. The surrogate can then transfer legal 
parenthood to the intended parents 6 weeks after birth of the child. Although cases in 
which surrogates decide not to relinquish the child are rare, this legal position carries 
some risk for the intended parents. The possibility of the surrogate not cooperating 
with the transfer of parental rights after birth may generate anxiety and make 
surrogacy less appealing as a reproductive option.37 For the surrogate, there is also 
a risk that intended parents may renege on the agreement, leaving her to take care 
of the child, especially in the event that the child is born with a disability or medical 
conditions. In disputes between intended parents and the surrogate, the courts will 
decide based on the child’s best interests; the child’s rights are deemed to be 
paramount in such cases, in line with the Children Act 1989 (England and Wales). 
However, at the time of writing, there is increasing pressure within the UK to review 
legislation so that genetic parents assume legal rights at birth.38  
While domestic surrogacy rates in the UK have remained relatively stable in recent 
years, a growing minority of prospective parents are utilising cross-border 
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regulations abroad, in addition to the difficulty of finding a surrogate domestically, 
especially when payment is limited or prohibited.39,40 However, utilising international 
surrogates does not bypass UK surrogacy legislation. Not only may issues 
surrounding the child’s legal recognition complicate attempts by the intended parents 
to travel home, but they are still required to apply for a parental order upon their 
return to the UK to become the child’s legal parents.41 Critics have also suggested 
that, from an ethical standpoint, cross-border commercial surrogacy from low-income 
countries is particularly problematic. Concerns centre around the surrogates’ 
autonomy and wellbeing, in addition to the potential for such arrangements to be 
exploitative. Major worries expressed here are that surrogates from low-income 
countries may be ‘coerced by poverty’, which invalidates their consent, and they are 
likely to be underpaid and maltreated by intended parents or commercial 
intermediaries.41,42 However, some cross-border surrogates have reported positive 
experiences. It could even be argued that surrogacy is a less exploitative and less 
harmful means of earning money than other available opportunities.43 
UK surrogates may be compensated with reasonable expenses only. A 2018 report 
by Surrogacy UK stated that the mean average compensation for domestic 
surrogacy at that time was £10,694.13; the highest reported in this survey was 
£23,500.44 Higher amounts were made for some international surrogacy 
arrangements between the USA and the UK, with one involving a payment of 
£96,000.44 So far, courts have usually taken a permissive view of relatively high 
expenses payments, with legal parenthood often being granted provided that it is 
perceived to be in the child’s best interests. A recent cross-sectional study suggests 
that the average cost of surrogacy in the UK is approximately £25,000. However, the 
costs associated with surrogacy vary dramatically internationally; in the USA, the 
median associated cost was found to be £120,000.39  
When considering the long-term outcomes in children born to surrogates, a recent 
systematic review revealed similar perinatal outcomes to IVF with oocyte donation.37 
Moreover, there are no major differences in psychological development compared 
with children born to nonsurrogates.37 A 10-year prospective study in the UK showed 
that families usually maintain good relationships with surrogate families. Most 
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The outcomes in surrogate mothers are also largely encouraging, with most 
reporting positive experiences. Analysis of 16 studies assessing long-term 
psychological outcomes found no long-lasting, serious psychopathology.37 However, 
some surrogates found it difficult to relinquish care of their born child to the intended 
parents.46 One study, in particular, demonstrated that more than one-third (35%) of 
surrogate mothers had such difficulties, although this reduced to 6% after 
12 months.46 Similarly, when considering long-term psychological outcomes of 
intended mothers and their relationships with their children, no major differences 
were shown when compared with mothers who conceive naturally.37  
 
Uterine transplantation  
UTx entails transplantation of the uterus, including the cervix, as well as the 
surrounding ligamentous tissues and supplying and draining blood vessels. UTx is 
the only therapeutic intervention that restores reproductive anatomy and functionality 
in women with AUFI. It not only enables the experience of gestation, but allows 
biological, social and legal parenthood, thereby avoiding some of the potential 
problems with surrogacy discussed above. 
In 2014, the first live birth following UTx was achieved in Sweden.47 This was 
achieved after a series of nine UTx procedures, which demonstrated the procedure’s 
feasibility using living donors.48 Eight live births have since been reported from this 
pivotal study,49 the success of which has paved the way for UTx procedures to be 
undertaken globally. The first live birth following UTx using a deceased donor was 
subsequently achieved in Brazil in 2017.50 While the details from several cases 
remain unpublished, a recent review of 45 UTx cases reported at least 18 live 
births12 and at least double this figure has been reported in the media, demonstrating 
that UTx is unquestionably feasible. However, more than one-quarter of cases 
required emergency hysterectomy and an additional 10% suffered complications 
necessitating further surgical intervention, thus highlighting the considerable 
associated risk involved.12  
UTx can be undertaken using either living or deceased donors. Each donor type 
presents differing advantages and disadvantages,51 and has distinct ethical 
implications.52,53 Using living donors has organisational advantages, including 
plentiful time to assess the recipient and donor preoperatively, as well as arrange the 
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currently not possible to evaluate clinical and reproductive outcomes in UTx cases 
between donor type, evidence shows that clinical outcomes in other solid organ 
transplants are better when living donors are used.54 However, the major advantage 
of using deceased donors is that risk to the donor is completely removed. In cases of 
living donor UTx so far, more than 1 in 10 donors have suffered a complication 
necessitating further surgical intervention,12 which highlights the risk involved when 
using living donors.  
Immunosuppression after UTx is essential and intensive follow-up is required to 
assess recovery, while monitoring for rejection and immunosuppression-related 
complications. Histological assessment of cervical biopsies is currently the only 
reliable method to detect rejection.48,55,56 After 6–12 months, following stabilisation 
on a nonteratogenic immunosuppression regimen, embryo transfers can be 
commenced.57 Using a single euploid blastocyst is recommended to optimise the 
probability of IVF success, while reducing the risk of multiple gestation.12 Following 
conception, high-risk pregnancy care should ensue, with expert maternofetal 
medicine input, with a view to deliver by caesarean section at 37 weeks of gestation, 
unless clinically indicated sooner. While consideration should be given to the risks of 
late preterm/early term delivery, such as transient tachypnoea of the newborn (TTN) 
and potentially inferior cognitive outcomes,58,59 the potential for painless labour 
brings potentially greater – albeit difficult to quantity – risk, with concerns regarding 
the structural integrity of the graft and how the vascular anastomoses would fare, 
following onset of contractions. Following birth, depending on reproductive plans and 
clinical condition, further embryo transfers can take place, or completion 
hysterectomy should be carried out. Following graft removal, transplant-related 
medications and immunosuppression can be stopped, thereby reducing long-term 
immunosuppression morbidity, such as infection and neoplasia.60,61 
UTx integrates complex bioethical debates from the fields of organ transplantation 
and assisted reproduction.62,63 Topics examined have included the welfare of 
children born through UTx,64,65 the values of reproductive autonomy and gestational 
parenthood,66,67 comparisons between surrogacy and UTx68,69 and broader 
questions surrounding publication, institutional requirements and research ethics.70 
UTx has also attracted criticism because alternative pathways to motherhood exist.71 
Some argue that if alternatives, such as adoption and surrogacy were presented and 
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providing UTx, undesirable attitudes towards parenthood might be reinforced and 
discriminatory social biases perpetuated; specifically, pronatalism (bias in favour of 
reproduction), gestationalism (bias in favour of gestational parenthood) and 
geneticism (bias in favour of genetic parenthood).72 These criticisms have also been 
specifically deployed against publicly funding UTx in countries with socialised 
medical care73,74 and in insurance-based or mixed systems.75 In this context, it has 
been argued that UTx improves on other options, such as surrogacy, only by 
satisfying personal desire to experience gestation and childbirth and that these are 
insufficient to justify the high financial cost associated with UTx, which has been 
estimated at almost €100,000 in European economies.76  
These arguments, however, can be challenged. Firstly, it is not possible to 
generalise about how suitable adoption and surrogacy really are for women with 
AUFI. Their appropriateness depends on individual circumstance, taking account of 
personal values, religious and/or cultural background and the legal context. In most 
countries, even if not prohibited, surrogacy remains socially and legally complex. In 
such circumstances, despite the considerable associated risk, UTx may be a 
reasonable preference.77 Secondly, concerns about discriminatory social bias look 
more like a critique of reproductive medicine in general than a specific reason to not 
offer UTx. That said, UTx is presently more difficult to justify than IVF owing to the 
comparatively high costs and risk level.62,63 Finally, it is difficult to ascertain why the 
mere existence of alternatives dictates the necessity to stop providing UTx. 
Interventions such as pinnaplasty, breast reconstruction after mastectomy and scalp 
cooling for chemotherapy are performed to enhance quality of life and protect people 
from hostile treatment for not conforming to prevailing norms. Arguments for UTx can 
be made on similar grounds and, even with alternatives available, UTx can be 
justified if it is in the woman’s interests.78 
Perceptions of UTx among women with AUFI already appear very positive, despite 
the relative infancy of the procedure. A UK study demonstrated that 97.5% of women 
with AUFI would choose UTx over surrogacy and adoption, despite being aware of 
the additional risks posed by UTx.3 Another study, specifically assessing perceptions 
in women with MRKH, showed that almost two-thirds of participants were motivated 
to undergo UTx, even after becoming aware of the associated risks.79 This is similar 
to the findings of a questionnaire in 60 women with AUFI in France, which found that 
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Given the additional risks associated with UTx, current selection criteria for a 
continuing UK research trial using deceased donors (Investigational Study Into 
Transplantation of the Uterus; INSITU) ensure recipients are aged 24–38, have a 
BMI <30 kg/m2 and normally functioning ovaries.81 Exclusion criteria include already 
having children, poor fitness and health or significant medical or psychiatric 
comorbidity, major or multiple previous abdominal surgery, or severe 
endometriosis.81 Moreover, potential recipients with a previous history of cancer 
must have been in remission for at least 5 years, owing to the risk of recurrence 
during this high-risk period82 when immunosuppression is commenced. Ethical and 
legal reasons mean it is likely that many of these selection criteria will be alleviated 
following transition into clinical practice;83,84 nevertheless, the selection criteria 
utilised to optimise success and safety will continue to restrict UTx availability among 
potential recipients.  
 
[Heading 1] Management  
In most cases, the diagnosis of AUFI is unexpected and can be highly traumatising, 
particularly when a woman has not yet completed her reproductive plans. Women 
with congenital causes, such as MRKH or other uterine anomalies, are often 
managed in specialist tertiary referral centres, where team members are 
experienced at sensitive diagnosis disclosure, arranging appropriate counselling and 
psychological support and offering management to optimise sexual function in those 
with suboptimal vaginal length.85,86 Given the rapid progress and demand for UTx 
among women with AUFI, and considering the anticipated transition into clinical care, 
the potential impact of the vaginal restoration method on future suitability for UTx 
should be contemplated. While dilator therapy,86 or the Vecchietti procedure,87 would 
create a physiologically functioning mucosal vagina, the creation of a neovagina 
using skin, peritoneum or intestine would probably create a dysbiotic environment 
that might affect future clinical and reproductive outcomes following UTx.88 As such, 
some UTx programmes currently exclude women with intestinal neovagina from 
undergoing UTx.81  
MRKH is traditionally considered a sporadic condition, owing to previously reported 
discordance between identical twins89 and the fact no females with MRKH have 
been born from surrogate pregnancies using oocytes from women with MRKH.90,91 
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females.92,93 Recent advancement in sequencing technologies has revealed the 
partially genetic makeup of MRKH.94-96 As such, genetic counselling is essential for 
women who wish to undergo surrogacy or UTx. In suspected familial cases, exome 
sequencing, or adoption, should be considered. 
Women with acquired causes of AUFI who have not yet completed their family, such 
as cases of emergency hysterectomy or development of Asherman’s syndrome, 
require similar reproductive counselling to those with congenital causes. It is 
essential to explore reproductive aspirations and to fully inform such women at the 
earliest opportunity so that realistic reproductive plans can be made in the context of 
their options. A suggested – albeit simplified – management algorithm is 
demonstrated in Figure 2. All women should receive extensive reproductive 
counselling about the options available to them, considering the advantages and 
disadvantages (as summarised in Table 1), including the associated legal and 
financial implications. Women who do not desire biologically related offspring ought 
to consider adoption. For those for whom biological relation is important, surrogacy 
and UTx should be primarily pursued, considering the limitations associated with 
surrogacy and the extensive selection criteria and risks involved with UTx. In such 
women, the implications of age upon ovarian reserve should be discussed, 
considering oocyte or embryo cryopreservation before the physiological decline in 
oocyte quality and quantity,97 to optimise future chances of success. 
 
[Heading 1] Conclusion 
At present, nearly all women with AUFI face a choice between involuntary 
childlessness and acquiring parenthood through adoption or surrogacy. The need for 
adoption continues to rise, with an annually increasing number of children in need of 
a permanent home. However, while undoubtedly beneficial for most adopted children 
and parents, the absence of a biological relationship, along with potential emotional, 
behavioural and relational issues, mean that prospective parents must think carefully 
about this option. Surrogacy offers a chance to have biologically related offspring, its 
outcomes are generally positive and multiple attempts are possible, thereby opening 
up the possibility for siblings in the future. However, in many jurisdictions, its legal 
position is problematic, which can cause uncertainty for, or make it difficult to 
commission, surrogates without going overseas. In addition, some cultures or 
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unacceptable. More than 70 UTx cases have now been undertaken and, following at 
least 18 live births after successful procedures, UTx is now considered a feasible 
fertility-restoring treatment for women with AUFI. However, it is associated with 
considerable surgical and immunosuppressive-related risk and, based on cases 
performed so far, a >25% risk of unplanned hysterectomy. The choices faced by 
women with AUFI are complex and sensitive. Women’s beliefs and preferences 
regarding parenthood are often rooted in, and engage with, deeply held aspirations 
and values. Extensive reproductive counselling is therefore essential for women with 
AUFI, in the context of collaborative multi-disciplinary care, to raise awareness of 
their options to acquire motherhood and the associated advantages and 
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[Figure legends] 
Figure 1. International variation of surrogacy law. 
Figure 2. Suggested management algorithm for options to acquire motherhood in 
women with absolute uterine factor infertility.  AUFI = absolute uterine factor infertility 
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Table 1. Advantages and disadvantages of the options for parenthood in women 
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Table 1. Advantages and disadvantages of the options for parenthood in women with 





Adoption  Acquires social and legal parenthood 
 Provides opportunity to enhance the 
life of a less fortunate child, with 
subsequent better psychological 




 Generally positive outcomes; three-
quarters of adoptive parents report 








 Potential for increased anxiety if not able 
to bond with child
23,24
 
 Challenging process: approximately 1 in 
10 adoptions report breaking down and 
one-quarter report finding it difficult
28
 
 Risk of disruption to current family unit 
Surrogacy  Allows biological relation to child 
 Following successful completion of 
parental order, legal parenthood is 
obtained 
 Excellent perinatal and long-term 
psychological outcomes in children, 
comparable to oocyte donation
37,45
  
 Excellent outcomes for intended 
parents, with similar psychological 




 More than one child can be attained, 
if relationship with surrogate remains 
positive, with the possibility of a 
second sibling 
 Ethical/cultural/religious barriers 




 In the UK, the surrogate is legally 
recognised as the mother at birth despite 
origin of the gametes and contractual 
agreements 




 Increased anxiety for intended parents: 
potential for surrogate not transferring 
parental rights after birth of child 
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Uterine 
transplant 
 Restores reproductive function, 
enabling the woman to experience 
gestation and childbirth 
 Allows biological relation to child 
 Automatically considered legal 
parents 
 Widely accepted across the main 
cultural/religious groups 
 More than one child can be attained 
with the possibility of a second 
pregnancy 
 Significant surgical risks related to 3–4 
open surgeries 
 Immunosuppression risks related to 
transient use while graft in situ 




 Exposure of additional risk to a second 
individual if using a living donor 
 Strict selection criteria curtail 
availability 


























Extensive counselling including 
assessment of availability, 
consideration of suitability 
based upon selection criteria, 
and informed decision after 
consideration of success rates 
and risks involved. 
Pre-operative evaluation to 
determine suitability, including 






Full counselling including realistic 
awareness of length and 
complexity of process, probability 
of !nding a suitable child to adopt, 
and consideration of outcomes in 
both children and parents
Full counselling including realistic 
expectation of !nding a surrogate, 
consideration of psychosocial impact, 
legal rami!cations, !nancial 
implications and religious context
Desire for 
gestation?
Available, suitable and 
consents to proceed?
Suitable and happy to 
proceed after consideration 
of alternatives?
Desire for 
biological relation?
Suitable, available 
and desirable?
No
Yes
Yes
Yes
Yes
No
No
No
No
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